Open report — full analysis, no account required.

Sign up to generate reports and read filings that aren't on the open list.

Sign up free

Get notified when BIAF files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: BIAF bioAffinity Technologies, Inc. 8-K

bioAffinity Technologies announces promotional webinar on CyPath Lung product

Filed June 2, 2026 · Period ending June 2, 2026 · ~1 min read

2 key changes 1 section

Key Changes

  • low

    Society for Advanced Bronchoscopy to host webinar on CyPath Lung's role in early-stage lung cancer detection and management. This is a promotional event with no disclosed financial impact.

  • low

    Filing references a press release dated June 2, 2026, but provides minimal detail beyond the webinar announcement. Event appears routine and promotional in nature.

    Exhibit 99.1 view on EDGAR →

Summary

bioAffinity Technologies filed an 8-K to announce that the Society for Advanced Bronchoscopy (SAB) will host a webinar featuring the company's CyPath Lung product. The webinar will focus on the product's expanding role in pulmonary, oncology, and surgical practices for detecting and managing early-stage lung cancer. This is a routine promotional disclosure with no material financial or operational impact announced.

For retail investors, this filing represents standard marketing activity rather than a business development that would affect the company's financial position or operations. Watch for any follow-up disclosures about actual adoption metrics, sales data, or partnerships that might result from increased awareness generated by such promotional events.

Section-by-Section Diff

Event · Item 9.01 — Financial Statements and Exhibits

~100 words

bioAffinity Technologies filed an 8-K referencing a press release dated June 2, 2026; no material event details disclosed in the filing body.

1 Added
Added Press release exhibit medium

Added in current filing · verify on EDGAR →

Press Release issued by bioAffinity Technologies, Inc., dated June 2, 2026

The 8-K references a press release dated June 2, 2026, but the filing body does not disclose the content or subject matter of the press release. Without access to Exhibit 99.1, the nature and materiality of the disclosed event cannot be determined from this filing.

Was this report useful?

Figures/quotes linked to EDGAR · Narrative written by AI · Jun 2, 2026 · How we verify